Springfield, IL  (CAPITOL CITY NOW) – The medical school in Springfield is part of a drug trial for a potential treatment for schizophrenia.“Valbenazine is an adjunct to the main treatment,” said principal investigator Dr. Obiora Onwuameze of Southern Illinois University School of Medicine, “and its job is to reduce some of the side effects that may come from anti-psychotics, (which are) the primary medications for treatment of schizophrenia.”

Onwuameze, currently searching for participants in the trial, says schizophrenics develop beliefs which are at odds with reality.

And, as we are hearing these days with depression and anxiety, “it’s okay not to be okay” with more severe conditions such as schizophrenia. “We feel that with the literature we have, with the data we have, that there is less stigma today compared to maybe twenty years ago.”

Click here for more information.